ActiveOps Plc (LON:AOM – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Monday. The company traded as low as GBX 95 and last traded at GBX 97.50, with a volume of 70,833 shares traded. The stock had previously closed at GBX 99.30.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group reduced their price objective on ActiveOps from GBX 355 to GBX 300 and set a “buy” rating for the company in a report on Monday, October 12th. One analyst has rated the stock with a Buy rating. According to MarketBeat, ActiveOps presently has an average rating of “Buy” and an average price target of GBX 300.
Get Our Latest Analysis on AOM
ActiveOps Stock Performance
The company has a market cap of £69.78 million, a PE ratio of -30.19 and a beta of 0.80. The company has a current ratio of 0.68, a quick ratio of 1.20 and a debt-to-equity ratio of 1.49. The business’s 50 day moving average is GBX 182.04 and its two-hundred day moving average is GBX 207.45.
Insider Activity
In other news, insider Emma Salthouse sold 25,269 shares of ActiveOps stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of GBX 190, for a total value of £48,011.10. Corporate insiders own 13.06% of the company’s stock.
About ActiveOps
ActiveOps’ offerings provide predictive and prescriptive insight to help service operations make better decisions – faster. The Company’s AI-powered SaaS solutions are underpinned by 15+ years of operational data and its AOM methodology that’s proven to drive cross department decision-making.
With Decision Intelligence, ActiveOps’ customers deliver MORE – release 20%+ capacity within the first 12 months and boost productivity by 30%+ leading to MORE business impact. Customer turnaround times are improved substantially, costs are reduced, SLAs are met, and employees are happier and more engaged.
Featured Articles
- Five stocks we like better than ActiveOps
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for ActiveOps Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ActiveOps and related companies with MarketBeat.com's FREE daily email newsletter.
